PCSK9 in chronic kidney disease.

about

Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering.

P2860

Q47363893-4E81B909-629D-49A5-9DEA-0194C8D95ADB Q54971522-5E558DC6-6DF2-40EE-B7B4-1AE55DD1F442

P2860

PCSK9 in chronic kidney disease.

Item

http://www.wikidata.org/entity/Q39022581

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

PCSK9 in chronic kidney disease.

@en

PCSK9 in chronic kidney disease.

@nl

type

Item

label

PCSK9 in chronic kidney disease.

@en

PCSK9 in chronic kidney disease.

@nl

prefLabel

PCSK9 in chronic kidney disease.

@en

PCSK9 in chronic kidney disease.

@nl

P1476

PCSK9 in chronic kidney disease.

@en

P2093

E Dounousi

http://www.w3.org/2001/XMLSchema#string

E Liberopoulos

http://www.w3.org/2001/XMLSchema#string

M Elisaf

http://www.w3.org/2001/XMLSchema#string

P Pavlakou

http://www.w3.org/2001/XMLSchema#string

P2860

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation

PCSK9: a key modulator of cardiovascular health

Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

P304

1015-1024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-017-1505-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28084558

http://www.w3.org/2001/XMLSchema#string

PCSK9 in chronic kidney disease.

about

P2860

P2860

PCSK9 in chronic kidney disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698